Incredible Pharmaceutical Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 6 Year, 5 Months
- Last Filing with ROC 31 Mar 2022
- Revenue Growth -30.12%
- Profit Growth -30.79%
- Ebitda -13.23%
- Net Worth 45.09%
- Total Assets -31.97%
About Incredible Pharmaceutical
Incredible Pharmaceutical Private Limited (IPPL) is a registered startup operating as a Private Limited Indian Non-Government Company incorporated in India on 30 August 2018 (Six years and five months 11 days old ). Its registered office is in Bulandshahr, Uttar Pradesh, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Gaurav Sharma and Arti Ojha serve as directors at the Company.
Company Details
-
Location
Bulandshahr, Uttar Pradesh, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U74999UP2018PTC107295
-
Company No.
107295
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
30 Aug 2018
-
Date of AGM
30 Sep 2022
-
Date of Balance Sheet
31 Mar 2022
-
Listing Status
Unlisted
-
ROC Code
Roc Kanpur
Industry
Who are the key members and board of directors at Incredible Pharmaceutical?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Gaurav Sharma
|
Director | 01-Jun-2020 | Current |
|
Arti Ojha
|
Director | 30-Aug-2018 | Current |
Financial Performance of Incredible Pharmaceutical.
Incredible Pharmaceutical Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 30.12% decrease. The company also saw a substantial fall in profitability, with a 30.79% decrease in profit. The company's net worth Soared by an impressive increase of 45.09%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Incredible Pharmaceutical?
Unlock access to Incredible Pharmaceutical's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Incredible Pharmaceutical?
Unlock and access historical data on people associated with Incredible Pharmaceutical, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Incredible Pharmaceutical, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Incredible Pharmaceutical's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
